These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33972874)

  • 41. Surface functionality density regulated
    Wan X; Wu L; Pei H; Ke H; Yang G; Tang J
    RSC Adv; 2018 May; 8(35):19420-19425. PubMed ID: 35540958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. pH-responsive drug release and real-time fluorescence detection of porous silica nanoparticles.
    Zhang X; Wang Y; Zhao Y; Sun L
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():19-26. PubMed ID: 28532020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells.
    Esfahani MKM; Alavi SE; Cabot PJ; Islam N; Izake EL
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
    Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
    Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pH-Triggered Drug Release Controlled by Poly(Styrene Sulfonate) Growth Hollow Mesoporous Silica Nanoparticles.
    Wibowo FR; Saputra OA; Lestari WW; Koketsu M; Mukti RR; Martien R
    ACS Omega; 2020 Mar; 5(8):4261-4269. PubMed ID: 32149256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface Immobilization of pH-Responsive Polymer Brushes on Mesoporous Silica Nanoparticles by Enzyme Mimetic Catalytic ATRP for Controlled Cargo Release.
    Zhou H; Wang X; Tang J; Yang YW
    Polymers (Basel); 2016 Aug; 8(8):. PubMed ID: 30974554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
    Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
    Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pH-responsive mesoporous silica nanocarriers based on layer-by-layer self-assembly.
    Zhang HY; Sun YF; Sun YL; Zhou M
    Biomed Mater Eng; 2014; 24(6):2211-8. PubMed ID: 25226920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid Injectable Sol-Gel Systems Based on Thermo-Sensitive Polyurethane Hydrogels Carrying pH-Sensitive Mesoporous Silica Nanoparticles for the Controlled and Triggered Release of Therapeutic Agents.
    Boffito M; Torchio A; Tonda-Turo C; Laurano R; Gisbert-Garzarán M; Berkmann JC; Cassino C; Manzano M; Duda GN; Vallet-Regí M; Schmidt-Bleek K; Ciardelli G
    Front Bioeng Biotechnol; 2020; 8():384. PubMed ID: 32509740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
    Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
    Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.
    Fan N; Liu R; Ma P; Wang X; Li C; Li J
    Colloids Surf B Biointerfaces; 2019 Apr; 176():122-129. PubMed ID: 30597409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Near-Infrared Light and pH-Responsive Polypyrrole@Polyacrylic acid/Fluorescent Mesoporous Silica Nanoparticles for Imaging and Chemo-Photothermal Cancer Therapy.
    Zhang M; Wang T; Zhang L; Li L; Wang C
    Chemistry; 2015 Nov; 21(45):16162-71. PubMed ID: 26494031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method.
    Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S
    Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release.
    Zhang M; Liu J; Kuang Y; Li Q; Zheng DW; Song Q; Chen H; Chen X; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2017 May; 98():691-700. PubMed ID: 28174081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-sensitive and bubble-generating mesoporous silica-based nanoparticles for enhanced tumor combination therapy.
    Zhang Z; Huang C; Zhang L; Guo Q; Qin Y; Fan F; Li B; Xiao B; Zhu D; Zhang L
    Acta Pharm Sin B; 2021 Feb; 11(2):520-533. PubMed ID: 33643828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.